✦ LIBER ✦

The Semen Quality of 1158 Men With Testicular Cancer at the Time of Cryopreservation: Results of the French National CECOS Network

✍ Scribed by Rives, N.; Perdrix, A.; Hennebicq, S.; Saias-Magnan, J.; Melin, M.-C.; Berthaut, I.; Barthelemy, C.; Daudin, M.; Szerman, E.; Bresson, J.-L.; Brugnon, F.; Bujan, L.

Book ID: 119924961
Publisher: American Society of Andrology
Year: 2012
Tongue: English
Weight: 212 KB
Volume: 33
Category: Article
ISSN: 1939-4640
DOI: 10.2164/jandrol.112.016592

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CRYOPRESERVATION OF SEMEN IN MEN WITH TE

CRYOPRESERVATION OF SEMEN IN MEN WITH TESTICULAR TUMOUR OR HODGKIN'S DISEASE: RESULTS OF ARTIFICIAL INSEMINATION OF THEIR PARTNERS

✍ SCAMMELL, G 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 264 KB

OUTCOME AMONG MEN WITH PATHOLOGICAL GLEA

OUTCOME AMONG MEN WITH PATHOLOGICAL GLEASON SUM 8-10 PROSTATE CANCER AT THE TIME OF RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE

✍ Lin, Daniel W; Terris, Martha K; Aronson, William J; Presti, Joseph C; Kane, Chr 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 126 KB

Effect of enzalutamide on time to first

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial

✍ Fizazi, Karim; Scher, Howard I; Miller, Kurt; Basch, Ethan; Sternberg, Cora N; C 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 337 KB

6112 POSTER Health-related Quality of Li

6112 POSTER Health-related Quality of Life at 12 Months in Patients With Metastatic Colorectal Cancer (mCRC) Initiating a Treatment With Bevacizumab (Bv) Plus Chemotherapy (CT) – Results From the CONCERT French Non Interventional Study

✍ Ducreux, M.; Phelip, J.M.; Andre, T.; Asselain, B.; Senellart, H.; Younes, W.; K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB